By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 





Company News
Bristol-Myers Squibb (BMY) Reports First Quarter Financial Results 4/28/2016 11:01:35 AM
Bristol-Myers Squibb (BMY) To Take Part In Deutsche Bank (DB) Annual Health Care Conference 4/27/2016 11:31:59 AM
Bristol-Myers Squibb (BMY)’s Opdivo Tagged a Breakthrough by the FDA for Head and Neck Cancer 4/25/2016 6:26:04 AM
Bristol-Myers Squibb (BMY) Selects Medidata Clinical Cloud To Drive Drug Development And Business Transformation 4/21/2016 10:08:31 AM
Eiger Biopharma Announces License Of Worldwide Rights To Pegylated Interferon Lambda-1a From Bristol-Myers Squibb (BMY) 4/21/2016 6:02:29 AM
Bristol-Myers Squibb (BMY) Release: First Presentation Of Overall Survival Data For Opdivo (Nivolumab) Shows Significant Survival Benefit At One-Year Versus Investigator’s Choice In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck 4/19/2016 8:22:35 AM
Bristol-Myers Squibb (BMY) Release: First Presentation Of Two-Year Overall Survival Data For Opdivo (Nivolumab) In Combination With Yervoy (Ipilimumab) Showed Superior Efficacy Versus Yervoy Alone In Advanced Melanoma 4/18/2016 11:28:48 AM
Bristol-Myers Squibb (BMY) To Support Americares And The Clinton Health Access Initiative, Inc. In A New Program Aimed At Treating Patients Co-Infected With Hepatitis C And HIV 4/15/2016 9:53:18 AM
Bristol-Myers Squibb (BMY) To Support Americares And The Clinton Health Access Initiative, Inc. In A New Program Aimed At Treating Patients Co-Infected With Hepatitis C And HIV 4/14/2016 11:18:23 AM
FDA Accepts For Priority Review Bristol-Myers Squibb (BMY)’s Supplemental Biologics License Application For Opdivo (Nivolumab) For The Treatment Of Classical Hodgkin Lymphoma Patients 4/14/2016 11:07:08 AM
12345678910...
//-->